Large-scale testing (Phase 3)Study completedNCT03713619
What this trial is testing
This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 544